Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)

Market Cap	10.82B
Revenue (ttm)	937.62M
Net Income (ttm)	314.96M
Shares Out	523.58M
EPS (ttm)	0.60
PE Ratio	34.35
Forward PE	30.38
Dividend	0.24 (1.16%)
Ex-Dividend Date	Jan 10, 2025

Volume	3,934,310
Average Volume	5,535,743
Open	20.13
Previous Close	20.89
Day's Range	20.13 - 21.05
52-Week Range	16.32 - 29.21
Beta	0.83
RSI	57.12
Earnings Date	Aug 25, 2025

About SHE:300357

Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally. The company offers Changdi, a dust mine drops; Changhao, an artemisia annua pollen allergen sublingual drops; Changdian, a dust mite skin prick diagnostic kit; and Changdian II, a house dust mite skin prick diagnosis kit. It also involved in the research and development of stem cells and medical artificial...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2002
• Employees: 1,679
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300357

Financial Performance

In 2024, SHE:300357's revenue was 925.39 million, an increase of 9.10% compared to the previous year's 848.19 million. Earnings were 317.82 million, an increase of 2.46%.